Inside Therapeutics
PrivateLast Round
VC Round
Jun 3, 2025
Total Funding Raised
$2.86M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Inside Therapeutics operates in Healthcare & Life Sciences and is based in Angoulême. Its latest recorded funding round was a VC Round in June 2025.
Inside Therapeutics is a biotechnology company that designs, develops, and markets microfluidic-based instruments for the formulation and manufacturing of lipid nanoparticles and RNA-LNP therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inside Therapeutics Comparables
Compare Inside Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DIANT Pharma Inc. | 80% | |
| 纳智达（上海）纳米技术有限公司 | 79% | |
| KNAUER Wissenschaftliche Geräte GmbH | 78% |
For institutional investors. Book with your work email.
Inside Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 3, 2025 | ||||
| Grant | May 21, 2025 | ||||
| Seed | Jun 20, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inside Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aquiti Gestion | VC Round |
| Newfund NAEH Innopy | Seed, VC Round |
| Bpifrance | Grant |
| SkalePark | Seed, VC Round |
| Région Pays de la Loire | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 149% MoM, reaching 22.5K.
- May 21, 2025
$1.47M grant received from Bpifrance and Région Pays de la Loire.
For institutional investors. Book with your work email.
Inside Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inside Therapeutics's valuation, stock price, and market status.
Is Inside Therapeutics a public or private company?
Inside Therapeutics is a private company.
What is the current stock price of Inside Therapeutics?
Inside Therapeutics is a private company, so its shares have no public market price. Caplight tracks Inside Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inside Therapeutics worth (valuation)?
Valuation information for Inside Therapeutics is not publicly available.
Can I buy Inside Therapeutics stock?
Inside Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inside Therapeutics's last funding round?
Inside Therapeutics's most recent funding round was VC Round on June 3, 2025.
Who are the main investors in Inside Therapeutics?
Key investors in Inside Therapeutics include Aquiti Gestion.
Will Inside Therapeutics IPO soon?
No public IPO plans have been announced for Inside Therapeutics.
How can I track Inside Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Inside Therapeutics's shares on secondary markets.